Literature DB >> 7691958

Stimulation of human basophils results in homotypic aggregation. A response independent of degranulation.

E F Knol1, T W Kuijpers, F P Mul, D Roos.   

Abstract

For a better insight into the mechanisms determining the recruitment of human basophilic granulocytes from the circulation to sites of allergic reactions, we studied the homotypic aggregation of these cells. The aggregation was studied with > 95% pure basophil suspensions obtained from peripheral blood in a double-color flow cytometric analysis. Homotypic aggregation was induced by treatment of the basophils with anti-IgE, house dust mite allergen, the chemoattractant FMLP, PMA, or IL-3. The aggregation by anti-IgE was, in part, mediated by interactions with Fc gamma R-II as indicated by 43 +/- 15% inhibition after pretreatment with CD32 antibodies. The aggregation was mediated by beta 2-integrins, as was shown by inhibition of the response by CD18 antibodies. The aggregation induced by anti-IgE, allergen, and PMA displayed comparable kinetics (t1/2 max, 3 to 4 min), in contrast to the degranulation of basophils. FMLP induced the most rapid response (t1/2max, 1.6 min). Inhibition of protein kinase C by staurosporine resulted in a strong (> 90%) inhibition of the PMA-induced aggregation, whereas the FMLP-induced aggregation was more than doubled (from 11.7 +/- 1.9 to 24.4 +/- 1.9%). Staurosporine did not affect the extent of the anti-IgE-induced aggregation, but it induced a retardation of congruent to 10 min. In most experiments, no clear correlation was found between degranulation and aggregation of human basophils. Most strikingly, IL-3 did not induce degranulation but did induce aggregation. Thus, the homotypic aggregation response of human basophils is induced by intracellular signals not necessarily leading to degranulation. This might be important in the physiologic appearance of basophils at sites of allergic late-phase responses or inflammation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691958

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  6 in total

1.  Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions.

Authors:  S Goto; Y Ikeda; E Saldívar; Z M Ruggeri
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

2.  Studies on the association between immunoglobulin E autoreactivity and immunoglobulin E-dependent histamine-releasing factors.

Authors:  Ilona Kleine Budde; Pleuni G de Heer; Susanne Natter; Vera Mahler; Jaring S van der Zee; Rudolf Valenta; Rob C Aalberse
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

3.  Oil body-associated hazelnut allergens including oleosins are underrepresented in diagnostic extracts but associated with severe symptoms.

Authors:  Laurian Zuidmeer-Jongejan; Montserrat Fernández-Rivas; Marcel Gt Winter; Jaap H Akkerdaas; Colin Summers; Ans Lebens; André C Knulst; Piet Schilte; Peter Briza; Gabriele Gadermaier; Ronald van Ree
Journal:  Clin Transl Allergy       Date:  2014-02-02       Impact factor: 5.871

4.  Increased expression levels of CD300c on basophils from allergic individuals.

Authors:  Joana Vitallé; Iñigo Terrén; Ane Orrantia; Aritza Segurola; Yolanda Seras; Pedro M Gamboa; Francisco Borrego; Olatz Zenarruzabeitia
Journal:  World Allergy Organ J       Date:  2019-09-30       Impact factor: 4.084

5.  Glutaraldehyde-Modified Recombinant Fel d 1: A Hypoallergen With Negligible Biological Activity But Retained Immunogenicity.

Authors:  Serge A Versteeg; Ingrid Bulder; Martin Himly; Toni M van Capel; R van den Hout; Stef J Koppelman; Esther C de Jong; Fatima Ferreira; Ronald van Ree
Journal:  World Allergy Organ J       Date:  2011-07-14       Impact factor: 4.084

6.  Differential response of human basophil activation markers: a multi-parameter flow cytometry approach.

Authors:  Salvatore Chirumbolo; Antonio Vella; Riccardo Ortolani; Marzia De Gironcoli; Pietro Solero; Giuseppe Tridente; Paolo Bellavite
Journal:  Clin Mol Allergy       Date:  2008-10-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.